レギュラトリーサイエンス分野

kunisawa kazuo

  (國澤 和生)

Profile Information

Affiliation
School of Health Sciences, Faculty of Medical Technology, Fujita Health University
Degree
博士(理学)(総合研究大学院大学)

Researcher number
60780773
J-GLOBAL ID
201701017137609291
researchmap Member ID
7000020076

External link

Papers

 28
  • Masaya Hasegawa, Moe Niijima, Kazuo Kunisawa, Tomoaki Teshigawara, Hisayoshi Kubota, Suwako Fujigaki, Hidetsugu Fujigaki, Yasuko Yamamoto, Hyoung-Chun Kim, Kuniaki Saito, Toshitaka Nabeshima, Akihiro Mouri
    Biochemical and Biophysical Research Communications, 737 150922-150922, Dec, 2024  
  • Hitomi Kurahashi, Kazuo Kunisawa, Kenji F. Tanaka, Hisayoshi Kubota, Masaya Hasegawa, Mai Miyachi, Yuka Moriya, Yoichi Hasegawa, Taku Nagai, Kuniaki Saito, Toshitaka Nabeshima, Akihiro Mouri
    Neuropsychopharmacology, Oct 11, 2024  Peer-reviewed
    Abstract Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by repetitive behaviors, social deficits, and cognitive impairments. Maternal use of valproic acid (VPA) during pregnancy is associated with an increased risk of ASD in offspring. The prevailing pathophysiological hypothesis for ASD involves excitation/inhibition (E/I) imbalances and serotonergic dysfunction. Here, we investigated the association between glutamatergic-serotonergic neuronal interactions and ASD-like behaviors in mice exposed to prenatal VPA. Prenatal VPA exposure induced excessive repetitive self-grooming behavior and impaired social behavior and object recognition memory in young adult period. Prenatal VPA mice showed hyper-glutamatergic function (increase in basal extracellular glutamate levels and CaMKII phosphorylation) and hypo-serotonergic function (decrease in 5-hydroxyindoleacetic acid and stimulation-induced serotonin [5-HT] release, but an increase in 5-HT transporter expression) in the prefrontal cortex. Treatment with a low-affinity NMDA receptor antagonist (memantine), a selective 5-HT reuptake inhibitor (fluoxetine), and a 5-HT1A receptor agonist (tandospirone) attenuated both the increase in CaMKII phosphorylation and ASD-like behavior of prenatal VPA mice. Opto-genetic activation of the serotonergic neuronal system attenuated impairments in social behavior and object recognition memory in prenatal VPA mice. WAY-100635—a 5-HT1A receptor antagonist—antagonized the effect of fluoxetine on impaired social behavior and object recognition memory. These results suggest that E/I imbalance and ASD-like behavior are associated with hypo-serotonergic receptor signaling through 5-HT1A receptors in prenatal VPA mice.
  • Hisayoshi Kubota, Kazuo Kunisawa, Masaya Hasegawa, Hitomi Kurahashi, Kazuhiro Kagotani, Yuki Fujimoto, Akihito Hayashi, Ryoji Sono, Takehiko Tsuji, Kuniaki Saito, Toshitaka Nabeshima, Akihiro Mouri
    Neurochemistry international, 180 105858-105858, Sep 12, 2024  Peer-reviewed
    High salt (HS) intake induces hypertension and cognitive impairment. Preventive strategies include against dietary supplements. Soybean lecithin is a widely used phospholipid supplement. Lysolecithin is important in cell signaling, digestion, and absorption. This study aimed to investigate the effects of lysophosphatidylcholine containing >70% of the total phospholipids (LPC70), on hypertension and cognitive impairment induced in mice by HS intake. Mice were provided with HS solution (2% NaCl in drinking water) with or without LPC70 for 12 weeks. Blood pressure, cognitive function, and inflammatory response of intestine were determined. Hypertension and impaired object recognition memory induced by HS intake were implicated with increased inducible nitric oxide synthase in the small intestine and tau hyperphosphorylation in the prefrontal cortex. LPC70 treatment prevented cognitive impairment by suppressing inducible nitric oxide synthase and tau hyperphosphorylation. LPC70 may be valuable as a functional food component in preventing HS-induced cognitive impairment.
  • Kazuo Kunisawa†, Mitsuki Hara, Koyo Yoshidomi, Yuki Kon, Yasuko Yamamoto, Suwako Fujigaki, Bolati Wulaer, Aika Kosuge, Moeka Tanabe, Sei Saitoh, Kazuo Takahashi, Kuniaki Saito, Toshitaka Nabeshima, Akihiro Mouri†, †corresponding authors
    Molecular Neurobiology, Jun 3, 2024  Peer-reviewedLead authorCorresponding author
  • Hitomi Kurahashi, Kazuo Kunisawa, Akihiro Mouri
    Methods in Molecular Biology, 331-340, Apr 18, 2024  Peer-reviewed

Major Misc.

 12

Major Presentations

 121

Major Teaching Experience

 20

Major Research Projects

 21